Close Menu
Global News HQ
    What's Hot

    Stars, Stripes, And A $4 Trillion Tab

    July 4, 2025

    Wordle today: Answer, hints for July 4, 2025

    July 4, 2025

    I’m Shopping Lululemon Scores, Discounted Hokas, and More This Fourth of July Weekend—Starting at $9

    July 4, 2025
    Recent Posts
    • Stars, Stripes, And A $4 Trillion Tab
    • Wordle today: Answer, hints for July 4, 2025
    • I’m Shopping Lululemon Scores, Discounted Hokas, and More This Fourth of July Weekend—Starting at $9
    • Jim Beam Just Unveiled the Next Batch of Its Barrel-Proof Booker’s Bourbon
    • Amazon reveals DeepFleet, its AI model developed for robotics
    Facebook X (Twitter) Instagram YouTube TikTok
    Trending
    • Stars, Stripes, And A $4 Trillion Tab
    • Wordle today: Answer, hints for July 4, 2025
    • I’m Shopping Lululemon Scores, Discounted Hokas, and More This Fourth of July Weekend—Starting at $9
    • Jim Beam Just Unveiled the Next Batch of Its Barrel-Proof Booker’s Bourbon
    • Amazon reveals DeepFleet, its AI model developed for robotics
    • A Secret Buyer Is Snapping up a Series of Million-Dollar Properties in Palm Beach
    • How You Disagree Matters Too, Breyer – See Also – Above the Law
    • WhiteRock founder to be extradited over $30M ZKasino case — ZachXBT
    Global News HQ
    • Technology & Gadgets
    • Travel & Tourism (Luxury)
    • Health & Wellness (Specialized)
    • Home Improvement & Remodeling
    • Luxury Goods & Services
    • Home
    • Finance & Investment
    • Insurance
    • Legal
    • Real Estate
    • More
      • Cryptocurrency & Blockchain
      • E-commerce & Retail
      • Business & Entrepreneurship
      • Automotive (Car Deals & Maintenance)
    Global News HQ
    Home - Finance & Investment - Why Summit Therapeutics Stock Soared 8% Higher Today | The Motley Fool
    Finance & Investment

    Why Summit Therapeutics Stock Soared 8% Higher Today | The Motley Fool

    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Why Summit Therapeutics Stock Soared 8% Higher Today | The Motley Fool
    Share
    Facebook Twitter LinkedIn Pinterest Email

    One day before the July Fourth holiday, the stock of clinical-stage biotech Summit Therapeutics (SMMT 8.18%) exploded like a powerful fireworks display. Shares of the cancer-focused company leaped by 8%, on a media report that a well-known peer was interested in a licensing deal. That rise bettered the S&P 500‘s (^GSPC 0.83%) 0.8% increase by several orders of magnitude.

    15 billion new reasons to consider the stock

    The media outlet in question was Bloomberg, which that morning published an article asserting that AstraZeneca is in talks with Summit about a partnership between the two companies.

    Image source: Getty Images.

    According to unnamed “people familiar with the matter,” the piece stated that such a partnership would center on the investigational lung cancer treatment ivonescimab. The drug, which Summit licenses from Chinese peer Akeso, has recently attracted much attention from the healthcare community and investors alike. This was due to its impressive performance in a late-stage clinical trial.

    Bloomberg’s sources said that the terms of a potential deal were still being hashed out. They might include an up-front payment of several billion dollars, and several milestone payments over time (this kind of structure is common in pharmaceutical industry licensing/partnership arrangements). All told, a deal between the two companies could pay out as much as $15 billion.

    Both Summit and AstraZeneca declined comment on the Bloomberg article.

    Fingers crossed

    When a drug development program attracts $15 billion worth of interest from a major industry player with deep pockets, it’s almost indisputably a win. If the Bloomberg report is accurate and a deal is indeed in the works (and is ultimately agreed upon), it would open a great, powerful, and quick road to success for Summit. It’s little wonder investors were so happy about the possibility.

    Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Summit Therapeutics. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.

    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleTrump’s ‘Big Beautiful Bill’ clears Congress after narrow House vote, what could this mean for Bitcoin?
    Next Article Hurry, Lowe’s Is Giving Away Free Ego Batteries for the 4th of July

    Related Posts

    Stars, Stripes, And A $4 Trillion Tab

    July 4, 2025

    Investor fright over Reeves’ tears shows fragility of UK finances

    July 3, 2025

    A Strong June Jobs Report Dashes Wall Street’s Hopes for a July Rate Cut Hopes: What the Experts Are Saying

    July 3, 2025

    Incyte: New CEO Brings A New Possible Outcome (NASDAQ:INCY)

    July 3, 2025
    Leave A Reply Cancel Reply

    ads
    Don't Miss
    Finance & Investment
    1 Min Read

    Stars, Stripes, And A $4 Trillion Tab

    Stars, Stripes, And A $4 Trillion Tab Source link

    Wordle today: Answer, hints for July 4, 2025

    July 4, 2025

    I’m Shopping Lululemon Scores, Discounted Hokas, and More This Fourth of July Weekend—Starting at $9

    July 4, 2025

    Jim Beam Just Unveiled the Next Batch of Its Barrel-Proof Booker’s Bourbon

    July 4, 2025
    Top
    Finance & Investment
    1 Min Read

    Stars, Stripes, And A $4 Trillion Tab

    Stars, Stripes, And A $4 Trillion Tab Source link

    Wordle today: Answer, hints for July 4, 2025

    July 4, 2025

    I’m Shopping Lululemon Scores, Discounted Hokas, and More This Fourth of July Weekend—Starting at $9

    July 4, 2025
    Our Picks
    Finance & Investment
    1 Min Read

    Stars, Stripes, And A $4 Trillion Tab

    Stars, Stripes, And A $4 Trillion Tab Source link

    Technology & Gadgets
    3 Mins Read

    Wordle today: Answer, hints for July 4, 2025

    Oh hey there! If you’re here, it must be time for Wordle. As always, we’re…

    Pages
    • About Us
    • Contact Us
    • Disclaimer
    • Homepage
    • Privacy Policy
    Facebook X (Twitter) Instagram YouTube TikTok
    • Home
    © 2025 Global News HQ .

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version